By Dr Claire Deakin

Conference Abstracts

Deakin CT; Ginn SL; Liao SH; Alexander IE, 2011, 'CONSTRUCTION AND VALIDATION OF A BARCODED LENTIVIRUS STOCK FOR INVESTIGATING SAFETY AND EFFICACY OF GENE THERAPY FOR X-LINKED SEVERE COMBINED IMMUNODEFICIENCY', in JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, Vol. 13, pp. 436 - 436, presented at 7th Biennial Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, 04 May 2011 - 06 May 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297950900049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Deakin CT; Alexander IE; Kerridge I, 2011, 'INVESTIGATING GENE THERAPY RESEARCHERS' ASSESSMENT OF RISKS IN CLINICAL TRIALS', in JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, Vol. 13, pp. 438 - 439, presented at 7th Biennial Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, 04 May 2011 - 06 May 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297950900054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Deakin CT; Kerridge I; Alexander IE, 2009, 'RISK ACCEPTABILITY IN CLINICAL RESEARCH: IS GENE THERAPY TOO RISK-AVERSE?', in JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, AUSTRALIA, Sydney, Vol. 11, pp. 852 - 852, presented at 6th Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Sydney, 29 April 2009 - 01 May 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270043300058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smyth CM; Ginn SL; Deakin CT; Logan GJ; Alexander IE, 2007, 'Limiting gamma c expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptors', in JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, AUSTRALIA, Shine Dome Acad Sci, Canberra, Vol. 9, pp. 529 - 529, presented at 5th Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Shine Dome Acad Sci, Canberra, 18 April 2007 - 20 April 2007, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247756300027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Preprints

Peckham H; Radziszewska A; de Gruijter NM; Restuadi R; Kartawinata M; Robinson GA; Martin-Gutierrez L; Deakin CT; Wedderburn LR; Jury EC; Butler G; Rosser EC; Ciurtin C, 2024, Oestrogen influences B cell class-switching in individuals with an XX sex chromosome complement, http://dx.doi.org/10.1101/2024.07.18.604160

Lin W-Y; Kartawinata M; Jebson BR; Restuadi R; Peckham H; Radziszewska A; Deakin C; Ciurtin C; Wedderburn LR; Wallace C, 2023, Penalised regression improves imputation of cell-type specific expression using RNA-seq data from mixed cell populations compared to domain-specific methods, http://dx.doi.org/10.1101/2023.09.11.556650

Deakin C; Cornish G; Ng K; Faulkner N; Bolland W; Panova V; Hope J; Rosa A; Harvey R; Hussain S; Earl C; Jebson B; Wilkinson MGL; Marshall L; O’Brien K; Rosser E; Radziszewska A; Peckham H; Heaney J; Rickman H; Paraskevopoulou S; Houlihan C; Spyer M; Gamblin S; McCauley J; Nastouli E; Cherepanov P; Ciurtin C; Wedderburn L; Kassiotis G, 2021, Favourable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases, http://dx.doi.org/10.1101/2021.02.15.431291

Peckham H; Gruijter ND; Raine C; Radziszewska A; Ciurtin C; Wedderburn LR; Rosser EC; Deakin C; Webb K, 2020, Sex-bias in COVID-19: a meta-analysis and review of sex differences in disease and immunity, http://dx.doi.org/10.21203/rs.3.rs-23651/v1

Peckham H; Gruijter ND; Raine C; Radziszewska A; Ciurtin C; Wedderburn L; Rosser E; Deakin C; Webb K, 2020, Sex-bias in COVID-19: a meta-analysis and review of sex differences in disease and immunity, http://dx.doi.org/10.21203/rs.3.rs-23651/v2

Shipa MRA; Heyer N; Mansoor R; Deakin CT; Madenidou A-V; Bouraioui A; Fisher C; Leandro M; Ciurtin C; Sen D, Adalimumab Superior to Etanercept as First Line Biologic in ERA- a Drug Survival Single Centre Study Spanning 10 Years, http://dx.doi.org/10.2139/ssrn.4048931

Peckham H; de Gruijter NM; Raine C; Radziszewska A; Ciurtin C; Wedderburn LR; Rosser EC; Deakin CT; Webb K, Sex-Bias in COVID-19: A Meta-Analysis and Review of Sex Differences in Disease and Immunity, http://dx.doi.org/10.2139/ssrn.3572881

Back to profile page